Comparison of mRNA and Protein Measures of Cytokines following Vaccination with Human Papillomavirus-16 L1 Virus-like Particles

Background: mRNA expression signatures are frequently used as surrogate measures of cellular function and pathway changes. Few studies have directly compared results obtained using gene expression and multiplex protein assays for corresponding gene products. Methods: We used data available from a clinical trial of a human papillomavirus-16 vaccine that tracked gene expression and cytokine/chemokine production by peripheral blood mononuclear cells stimulated in culture with various antigens to evaluate the degree to which gene expression levels reflect observed levels of cytokines/chemokines. Twenty-six women enrolled in a phase II clinical trial of a human papillomavirus-16 vaccine were evaluated for gene expression (using the Affymetrix Human Genome Focus Array) and cytokine/chemokine levels (using a bead-based 22-plex cytokine assay developed by Linco Research, Inc.) before and after vaccination. Results: Our results suggest the presence of a wide range of correlations between mRNA expression and secreted protein levels. The strongest correlation was observed for IFN-γ (R = 0.90 overall levels; R = 0.69 when vaccine induced changes were evaluated). More modest overall correlations ranging from 0.40 to 0.80 were observed for MIP1A, IP10, TNF-α, MCP1, IL-2, GM-CSF, IL-5, RANTES, and IL-8. Weaker or no correlation was observed between gene expression and protein levels for the remaining cytokines/chemokines evaluated. Conclusion: The degree of correlation between gene expression and protein levels varied among different cytokines/chemokines. Impact: Researchers should be cautious when using mRNA expression array results as a proxy for protein levels using existing technologies. Cancer Epidemiol Biomarkers Prev; 19(4); 978–81. ©2010 AACR.

[1]  E. Marcotte,et al.  Global signatures of protein and mRNA expression levelsw , 2009 .

[2]  V. Seyfert-Margolis,et al.  Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays , 2009, BMC Immunology.

[3]  L. Dodd,et al.  Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients1 , 2009, The Journal of Immunology.

[4]  Gerhard Walzl,et al.  An Evaluation of Commercial Fluorescent Bead-Based Luminex Cytokine Assays , 2008, PloS one.

[5]  R. Pili,et al.  Posttranscription Regulation of Prostate Cancer Growth , 2008, Cancer journal.

[6]  M. Kozak.  Some thoughts about translational regulation: Forward and backward glances , 2007, Journal of cellular biochemistry.

[7]  L. Dodd,et al.  Cytokine and Chemokine Profiles following Vaccination with Human Papillomavirus Type 16 L1 Virus-Like Particles , 2007, Clinical and Vaccine Immunology.

[8]  Gary Hardiman,et al.  Microarrays Technologies 2006: an overview. , 2006, Pharmacogenomics.

[9]  Gang Wu,et al.  Correlation of mRNA Expression and Protein Abundance Affected by Multiple Sequence Features Related to Translational Efficiency in Desulfovibrio vulgaris: A Quantitative Analysis , 2006, Genetics.

[10]  Katrin Hoffmann,et al.  Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR – how well do they correlate? , 2005, BMC Genomics.

[11]  Andrew Emili,et al.  Integrating gene and protein expression data: pattern analysis and profile mining. , 2005, Methods.

[12]  C. Hack,et al.  Integrated transcriptome and proteome data: the challenges ahead. , 2004, Briefings in functional genomics & proteomics.

[13]  V. Thorsson,et al.  Integrated Genomic and Proteomic Analyses of Gene Expression in Mammalian Cells*S , 2004, Molecular & Cellular Proteomics.

[14]  J. P. McCoy,et al.  Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers , 2004, Cytometry. Part B, Clinical cytometry.

[15]  L. Melton.  Protein arrays: Proteomics in multiplex , 2004, Nature.

[16]  Vassily Hatzimanikatis,et al.  Insights into the relation between mRNA and protein expression patterns: I. theoretical considerations , 2003, Biotechnology and bioengineering.

[17]  Vassily Hatzimanikatis,et al.  Insights into the relation between mrna and protein expression patterns: ii. Experimental observations in Escherichia coli 1 , 2003, Biotechnology and bioengineering.

[18]  R. Lempicki,et al.  Evaluation of gene expression measurements from commercial microarray platforms. , 2003, Nucleic acids research.

[19]  J. Berzofsky,et al.  Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. , 2003, The Journal of infectious diseases.

[20]  S. Loening,et al.  Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. , 2002, European urology.

[21]  L. Hood,et al.  Complementary Profiling of Gene Expression at the Transcriptome and Proteome Levels in Saccharomyces cerevisiae*S , 2002, Molecular & Cellular Proteomics.

[22]  David E. Misek,et al.  Discordant Protein and mRNA Expression in Lung Adenocarcinomas * , 2002, Molecular & Cellular Proteomics.

[23]  S. Hanash,et al.  Identification of androgen‐regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis , 2001, Proteomics.

[24]  Hongfang Liu,et al.  Microarray probes and probe sets. , 2010, Frontiers in bioscience.

[25]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[26]  J. Seilhamer,et al.  A comparison of selected mRNA and protein abundances in human liver , 1997, Electrophoresis.